Cargando…
Comprehensive Phenotyping in Multiple Sclerosis: Discovery Based Proteomics and the Current Understanding of Putative Biomarkers
Currently, there is no single test for multiple sclerosis (MS). Diagnosis is confirmed through clinical evaluation, abnormalities revealed by magnetic resonance imaging (MRI), and analysis of cerebrospinal fluid (CSF) chemistry. The early and accurate diagnosis of the disease, monitoring of progress...
Autores principales: | O’Connor, Kevin C., Roy, Sushmita Mimi, Becker, Christopher H., Hafler, David A., Kantor, Aaron B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
IOS Press
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3851054/ https://www.ncbi.nlm.nih.gov/pubmed/17124343 http://dx.doi.org/10.1155/2006/670439 |
Ejemplares similares
-
Comprehensive phenotyping and biological marker discovery
por: Kantor, Aaron B.
Publicado: (2002) -
Shotgun Proteomics and Biomarker Discovery
por: McDonald, W. Hayes, et al.
Publicado: (2002) -
Proteomics as a Tool for Biomarker Discovery
por: Kohn, Elise C., et al.
Publicado: (2007) -
The Use of Proteomics in Biomarker Discovery in Neurodegenerative Diseases
por: Davidsson, Pia, et al.
Publicado: (2005) -
A Proteomic Approach for the Discovery of Early Detection Markers of Hepatocellular Carcinoma
por: Steel, Laura F., et al.
Publicado: (2001)